 |
|
|
| |
Excellent Efficacy and Safety of Sofosbuvir, Glecaprevir, Pibrentasvir and Ribavirin for Retreatment of Chronic Hepatitis C after Sofosbuvir, Velpatasvir and Voxilaprevir Failure
|
| |
| |
AASLD 2021 Nov 12-15
Varun Saxena, MD MAS1,2; Jeff McKinney2; Scott L. Chamberland1; Lisa Catalli2; Suk I. Seo, MD1; Joanna B. Ready, MD1; Jennifer C. Price, MD PhD2
1Kaiser Permanente Northern California
2University of California San Francisco
|
| |
|
|
|
|
|
